Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE

Schreiber, S; Rogler, G; Watanabe, M; Vermeire, S; Maaser, C; Danese, S; Faes, M; Van Hoek, P; Hsieh, JRY; Moerch, U; Zhou, Y; de Haas, A; Rudolph, C; Oortwijn, A; Loftus, EV Jr

Schreiber, S (通讯作者)，Univ Hosp Schleswig Holstein, Dept Med 1, Arnold Heller Str 3, D-24105 Kiel, Germany.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023; 58 (9): 874

Abstract

Background: Filgotinib 200 mg (FIL200) is an approved treatment for adults with moderately to severely active ulcerative colitis (UC).Aim: To report i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索